Literature DB >> 25921537

DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function.

Qiujing Yu1, Yuliya V Katlinskaya1, Christopher J Carbone1, Bin Zhao1, Kanstantsin V Katlinski1, Hui Zheng1, Manti Guha1, Ning Li1, Qijun Chen2, Ting Yang2, Christopher J Lengner1, Roger A Greenberg2,3, F Brad Johnson2, Serge Y Fuchs1.   

Abstract

Expression of type I interferons (IFNs) can be induced by DNA-damaging agents, but the mechanisms and significance of this regulation are not completely understood. We found that the transcription factor IRF3, activated in an ATM-IKKα/β-dependent manner, stimulates cell-autonomous IFN-β expression in response to double-stranded DNA breaks. Cells and tissues with accumulating DNA damage produce endogenous IFN-β and stimulate IFN signaling in vitro and in vivo. In turn, IFN acts to amplify DNA-damage responses, activate the p53 pathway, promote senescence, and inhibit stem cell function in response to telomere shortening. Inactivation of the IFN pathway abrogates the development of diverse progeric phenotypes and extends the lifespan of Terc knockout mice. These data identify DNA-damage-response-induced IFN signaling as a critical mechanism that links accumulating DNA damage with senescence and premature aging.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921537      PMCID: PMC4426031          DOI: 10.1016/j.celrep.2015.03.069

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  68 in total

Review 1.  Viruses and interferon: a fight for supremacy.

Authors:  Michael G Katze; Yupeng He; Michael Gale
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

Review 2.  Aging, cellular senescence, and cancer.

Authors:  Judith Campisi
Journal:  Annu Rev Physiol       Date:  2012-11-08       Impact factor: 19.318

3.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

4.  Interferon regulatory factor-3 is an in vivo target of DNA-PK.

Authors:  Alla Y Karpova; Maren Trost; John M Murray; Lewis C Cantley; Peter M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Authors:  Liufu Deng; Hua Liang; Meng Xu; Xuanming Yang; Byron Burnette; Ainhoa Arina; Xiao-Dong Li; Helena Mauceri; Michael Beckett; Thomas Darga; Xiaona Huang; Thomas F Gajewski; Zhijian J Chen; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

Review 6.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

7.  Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.

Authors:  Federica Moschella; Giovanni Fernando Torelli; Mara Valentini; Francesca Urbani; Carla Buccione; Maria Teresa Petrucci; Fiammetta Natalino; Filippo Belardelli; Robin Foà; Enrico Proietti
Journal:  Clin Cancer Res       Date:  2013-06-12       Impact factor: 12.531

8.  Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function.

Authors:  Kuti Baruch; Aleksandra Deczkowska; Eyal David; Joseph M Castellano; Omer Miller; Alexander Kertser; Tamara Berkutzki; Zohar Barnett-Itzhaki; Dana Bezalel; Tony Wyss-Coray; Ido Amit; Michal Schwartz
Journal:  Science       Date:  2014-08-21       Impact factor: 47.728

9.  Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination.

Authors:  Jiangbo Tang; Nam Woo Cho; Gaofeng Cui; Erica M Manion; Niraj M Shanbhag; Maria Victoria Botuyan; Georges Mer; Roger A Greenberg
Journal:  Nat Struct Mol Biol       Date:  2013-02-03       Impact factor: 15.369

10.  Chronic inflammation induces telomere dysfunction and accelerates ageing in mice.

Authors:  Diana Jurk; Caroline Wilson; João F Passos; Fiona Oakley; Clara Correia-Melo; Laura Greaves; Gabriele Saretzki; Chris Fox; Conor Lawless; Rhys Anderson; Graeme Hewitt; Sylvia Lf Pender; Nicola Fullard; Glyn Nelson; Jelena Mann; Bart van de Sluis; Derek A Mann; Thomas von Zglinicki
Journal:  Nat Commun       Date:  2014-06-24       Impact factor: 14.919

View more
  98 in total

1.  Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Audrey Lasri; Ning Li; Daniel P Beiting; Amy C Durham; Ting Yang; Eli Pikarsky; Christopher J Lengner; F Brad Johnson; Yinon Ben-Neriah; Serge Y Fuchs
Journal:  Mol Cell Biol       Date:  2016-01-25       Impact factor: 4.272

2.  PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing.

Authors:  Megan Kissig; Jeff Ishibashi; Matthew J Harms; Hee-Woong Lim; Rachel R Stine; Kyoung-Jae Won; Patrick Seale
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

3.  Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians.

Authors:  Gianluca Storci; Sabrina De Carolis; Alessio Papi; Maria Giulia Bacalini; Noémie Gensous; Elena Marasco; Anna Tesei; Francesco Fabbri; Chiara Arienti; Michele Zanoni; Anna Sarnelli; Spartaco Santi; Fabiola Olivieri; Emanuela Mensà; Silvia Latini; Manuela Ferracin; Stefano Salvioli; Paolo Garagnani; Claudio Franceschi; Massimiliano Bonafè
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

4.  Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.

Authors:  Yuliya V Katlinskaya; Kanstantsin V Katlinski; Qiujing Yu; Angelica Ortiz; Daniel P Beiting; Angela Brice; Diwakar Davar; Cindy Sanders; John M Kirkwood; Hallgeir Rui; Xiaowei Xu; Constantinos Koumenis; J Alan Diehl; Serge Y Fuchs
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

5.  Type 1 interferons contribute to the clearance of senescent cell.

Authors:  Yuliya V Katlinskaya; Christopher J Carbone; Qiujing Yu; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

6.  Interferon-α signaling promotes embryonic HSC maturation.

Authors:  Peter Geon Kim; Matthew C Canver; Catherine Rhee; Samantha J Ross; June V Harriss; Ho-Chou Tu; Stuart H Orkin; Haley O Tucker; George Q Daley
Journal:  Blood       Date:  2016-04-19       Impact factor: 22.113

Review 7.  DNA repair and systemic lupus erythematosus.

Authors:  Rithy Meas; Matthew J Burak; Joann B Sweasy
Journal:  DNA Repair (Amst)       Date:  2017-06-09

8.  Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

Authors:  Wei Shi; Therese Vu; Didier Boucher; Anna Biernacka; Jules Nde; Raj K Pandita; Jasmin Straube; Glen M Boyle; Fares Al-Ejeh; Purba Nag; Jessie Jeffery; Janelle L Harris; Amanda L Bain; Marta Grzelak; Magdalena Skrzypczak; Abhishek Mitra; Norbert Dojer; Nicola Crosetto; Nicole Cloonan; Olivier J Becherel; John Finnie; Jeffrey R Skaar; Carl R Walkley; Tej K Pandita; Maga Rowicka; Krzysztof Ginalski; Steven W Lane; Kum Kum Khanna
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

9.  Negative regulation of type I IFN signaling by phosphorylation of STAT2 on T387.

Authors:  Yuxin Wang; Jing Nan; Belinda Willard; Xin Wang; Jinbo Yang; George R Stark
Journal:  EMBO J       Date:  2016-11-16       Impact factor: 11.598

10.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.